128 related articles for article (PubMed ID: 33120555)
1. Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response.
Hattaf K; Yousfi N
Math Biosci Eng; 2020 Aug; 17(5):5326-5340. PubMed ID: 33120555
[TBL] [Abstract][Full Text] [Related]
2. The within-host viral kinetics of SARS-CoV-2.
Li CT; Xu JH; Liu JW; Zhou YC
Math Biosci Eng; 2020 Mar; 17(4):2853-2861. PubMed ID: 32987502
[TBL] [Abstract][Full Text] [Related]
3. Herd Immunity: Understanding COVID-19.
Randolph HE; Barreiro LB
Immunity; 2020 May; 52(5):737-741. PubMed ID: 32433946
[TBL] [Abstract][Full Text] [Related]
4. Wrong but Useful - What Covid-19 Epidemiologic Models Can and Cannot Tell Us.
Holmdahl I; Buckee C
N Engl J Med; 2020 Jul; 383(4):303-305. PubMed ID: 32412711
[No Abstract] [Full Text] [Related]
5. New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes".
Xu G; Ye M; Zhao J; Liu F; Ma W
Geroscience; 2020 Oct; 42(5):1225-1227. PubMed ID: 32710258
[No Abstract] [Full Text] [Related]
6. Modeling infectious disease dynamics.
Cobey S
Science; 2020 May; 368(6492):713-714. PubMed ID: 32332062
[No Abstract] [Full Text] [Related]
7. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
Xu W; Wang M; Yu D; Zhang X
Front Immunol; 2020; 11():565278. PubMed ID: 33013929
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling of COVID-19 transmission: the roles of intervention strategies and lockdown.
Bugalia S; Bajiya VP; Tripathi JP; Li MT; Sun GQ
Math Biosci Eng; 2020 Sep; 17(5):5961-5986. PubMed ID: 33120585
[TBL] [Abstract][Full Text] [Related]
9. High population densities catalyse the spread of COVID-19.
Rocklöv J; Sjödin H
J Travel Med; 2020 May; 27(3):. PubMed ID: 32227186
[No Abstract] [Full Text] [Related]
10. Assessing the severity of COVID-19.
Freitas ARR; Napimoga M; Donalisio MR
Epidemiol Serv Saude; 2020 Apr; 29(2):e2020119. PubMed ID: 32267300
[No Abstract] [Full Text] [Related]
11. SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.
Cossarizza A; De Biasi S; Guaraldi G; Girardis M; Mussini C;
Cytometry A; 2020 Apr; 97(4):340-343. PubMed ID: 32187834
[No Abstract] [Full Text] [Related]
12. Coronavirus in China.
Burki TK
Lancet Respir Med; 2020 Mar; 8(3):238. PubMed ID: 32027848
[No Abstract] [Full Text] [Related]
13. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
Goudsmit J
Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914
[No Abstract] [Full Text] [Related]
14. Optimal control strategies for the transmission risk of COVID-19.
Lemecha Obsu L; Feyissa Balcha S
J Biol Dyn; 2020 Dec; 14(1):590-607. PubMed ID: 32696723
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2.
Breiman A; Ruvën-Clouet N; Le Pendu J
PLoS Pathog; 2020 May; 16(5):e1008556. PubMed ID: 32437478
[No Abstract] [Full Text] [Related]
16. The «moonlighting protein» able to explain the T
Roncati L; Lusenti B
Med Hypotheses; 2020 Oct; 143():110087. PubMed ID: 32679426
[TBL] [Abstract][Full Text] [Related]
17. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
18. The COVID-19 pandemic.
Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 pandemics: The lack of critical reflection addressing short- and long-term challenges.
Correia T
Int J Health Plann Manage; 2020 May; 35(3):669-672. PubMed ID: 32237159
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
